Cramer’s lightning round: Not recommending Nio or any Chinese stocks
Veru: "Veru is in for a very important breast cancer indication. They just got fast-track designation by the FDA this morning. It's at $5. It made no sense that the stock didn't go up to me. I thought it should've been up on the news."…